Skip to content
Axcess News – Lifestyle
Author:
Crescent Biopharma, Inc.
Crescent Biopharma to Present at March Investor Conferences
March 5, 2026
Crescent Biopharma Announces Grants of Inducement Awards
March 5, 2026
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
March 4, 2026
←
Previous Page
1
2